6.1 Recent clinical trials targeting RCD pathways in melanoma and emerging evidence Recent advances in clinical research have witnessed the initiation of multiple trials evaluating RCD-targeted therapies in melanoma, providing preliminary evidence for their safety, efficacy, and predictive biomarkers
SGLT2 knockdown restores the Th17/Treg balance and suppresses diabetic nephropathy in db/db mice by regulating SGK1 via Na
With a simple design [] Learn More Featured
Testosterone therapy can actually cause an increase in red blood cell production
Andrew Proctor, Chief Executive of the National Eczema Society, highlighted, Atopic eczema can profoundly impact patients and their families, influencing everyday decisions from clothing choices to participation in activities due to its physical symptoms of itching, soreness, and skin irritation